Geneos Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Geneos Wealth Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,638	Closed	-$127K	–	2954
2021 Q1	$127K	Buy	+1,638	New	+$151K	﹤0.01%	1189
2017 Q2	–	Sell	-400	Closed	-$34K	–	2099
2017 Q1	$34K	Hold	400	–	–	﹤0.01%	1032
2016 Q4	$25K	Hold	400	–	–	﹤0.01%	1094
2016 Q3	$25K	Hold	400	–	–	﹤0.01%	1048
2016 Q2	$21K	Hold	400	–	–	﹤0.01%	1101
2016 Q1	$16K	Buy	+400	New	+$18.6K	﹤0.01%	1158

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Geneos Wealth Management's LKFT Position: Q2 2021 in Review

Geneos Wealth Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 1,638 shares — an estimated $127K sold.

Geneos Wealth Management first reported a position in LKFT in Q1 2016 and held it in 6 quarters. The position peaked at $127K in Q1 2021. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Geneos Wealth Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Geneos Wealth Management sold 1,638 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $127K.
Geneos Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2016 and held it in 6 quarters.
Geneos Wealth Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $127K in Q1 2021.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.